A carregar...

Quantitative characterization of the mechanism of action and impact of a ‘proteolysis-permitting’ anti-PCSK9 antibody

A recent report described a novel mechanism of action for an anti-proprotein convertase subtilisin-kexin type 9 (PCSK9) monoclonal antibody (LY3015014, or LY), wherein the antibody has improved potency and duration of action due to the PCSK9 epitope for LY binding. Unlike other antibodies, proteolys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Hansen, Ryan J., Berna, Michael J., Sperry, Andrea E., Beyer, Thomas P., Wroblewski, Victor J., Schroeder, Krista M., Eacho, Patrick I.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5297531/
https://ncbi.nlm.nih.gov/pubmed/27981884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1270490
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!